Notice: This CMS-approved document has been submitted - Philips ...
Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...
CMS-1403-FC patients required by applicable reporting criteria (described above in section II.O1.b.ii.). TABLE 19: Final Measures Selected for 2009 Diabetes Mellitus Measures Group Measure Title Measure Source 1. Diabetes Mellitus: Hemoglobin A1c Poor Control in Diabetes Mellitus NCQA 2. Diabetes Mellitus: Low Density Lipoprotein (LDL-C) Control in Diabetes Mellitus NCQA 3. Diabetes Mellitus: High Blood Pressure Control in Diabetes Mellitus NCQA 117. Diabetes Mellitus: Dilated Eye Exam in Diabetic Patient NCQA 119. Diabetes Mellitus: Urine Screening for Microalbumin or Medical Attention for Nephropathy in Diabetic Patients NCQA Diabetes Mellitus: Foot Exam NCQA TABLE 20: Final Measures Selected for 2009 CKD Measures Group Measure Title Measure Source 121. Chronic Kidney Disease (CKD): Laboratory Testing (Calcium, AMA-PCPI Phosphorus, Intact Parathyroid Hormone (iPTH) and Lipid Profile) 122. Chronic Kidney Disease (CKD): Blood Pressure Management AMA-PCPI 123. Chronic Kidney Disease (CKD): Plan of Care: Elevated Hemoglobin for Patients Receiving Erythropoiesis - Stimulating Agents (ESA) AMA-PCPI Chronic Kidney Disease (CKD): Referral for Arteriovenous AV) Fistula AMA-PCPI Chronic Kidney Disease (CKD): Influenza Immunization AMA-PCPI TABLE 21: Final Measures Selected for 2009 Preventive Care Measures Group Measure Title Measure Source 39. Screening or Therapy for Osteoporosis for Women Aged 65 Years and Older AMA-PCPI/NCQA 48. Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older AMA-PCPI/NCQA 110. Preventive Care and Screening: Influenza Immunization for Patients ≥ 50 AMA-PCPI Years Old 111. Preventive Care and Screening: Pneumonia Vaccination for Patients 65 years and Older NCQA 112. Preventive Care and Screening: Screening Mammography NCQA 113. Preventive Care and Screening: Colorectal Cancer Screening NCQA 114. Preventive Care and Screening: Inquiry Regarding Tobacco Use AMA-PCPI 650
CMS-1403-FC Measure Title Measure Source 115. Preventive Care and Screening: Advising Smokers to Quit NCQA 128. Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up QIP/CMS In addition to the three measures groups retained from 2008 with applicable modifications, there are four new measures groups that we are finalizing for the 2009 PQRI: (1) CABG Surgery; 2) Rheumatoid Arthritis; 3) Perioperative Care; and (4) Back Pain. Each of the measures groups contains at least four PQRI measures. Tables 22 through 25 lists the measures selected for inclusion in each of these new measures groups. TABLE 22: Final Measures Selected for 2009 CABG Measures Group Measure Title Measure Source 43. Coronary Artery Bypass Graft (CABG): Use of Internal Mammary Artery (IMA) in Isolated CABG Surgery STS 44. Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Surgery STS Coronary Artery Bypass Graft (CABG): Prolonged Intubation STS (Ventilation) + Coronary Artery Bypass Graft (CABG): Deep Sternal Wound Infection Rate + Coronary Artery Bypass Graft (CABG): Stroke/Cerebrovascular Accident (CVA) + Coronary Artery Bypass Graft (CABG): Post-operative Renal Insufficiency + Coronary Artery Bypass Graft (CABG): Surgical Re-exploration + STS Coronary Artery Bypass Graft (CABG): Anti-platelet Medications at STS Discharge + Coronary Artery Bypass Graft (CABG): Beta Blockers Administered at Discharge + Coronary Artery Bypass Graft (CABG): Lipid Management and Counseling + + This measure is reportable only via registry-based reporting and is not reportable via claims-based reporting. STS STS STS STS STS 651
- Page 599 and 600: CMS-1403-FC the AMA-PCPI should be
- Page 601 and 602: CMS-1403-FC are appropriate and do
- Page 603 and 604: CMS-1403-FC to make any changes to
- Page 605 and 606: CMS-1403-FC post the measures for p
- Page 607 and 608: CMS-1403-FC beneficiaries. We now h
- Page 609 and 610: CMS-1403-FC identified in Tables 15
- Page 611 and 612: CMS-1403-FC important difference in
- Page 613 and 614: CMS-1403-FC not use Measures #73 Ca
- Page 615 and 616: CMS-1403-FC measures, but which are
- Page 617 and 618: CMS-1403-FC with comment period. Ho
- Page 619 and 620: CMS-1403-FC ● Measure #41 Osteopo
- Page 621 and 622: CMS-1403-FC professional to simply
- Page 623 and 624: CMS-1403-FC measures. We consider t
- Page 625 and 626: CMS-1403-FC Measure Number and Titl
- Page 627 and 628: CMS-1403-FC Measure Number and Titl
- Page 629 and 630: CMS-1403-FC ● Measure #120 CKD: A
- Page 631 and 632: CMS-1403-FC For the 2009 PQRI quali
- Page 633 and 634: CMS-1403-FC rule indicated that the
- Page 635 and 636: CMS-1403-FC Response: As suggested
- Page 637 and 638: CMS-1403-FC required for the measur
- Page 639 and 640: CMS-1403-FC ● Achievement of NQF
- Page 641 and 642: CMS-1403-FC These additional measur
- Page 643 and 644: CMS-1403-FC We did not include this
- Page 645 and 646: CMS-1403-FC Comment: Many commenter
- Page 647 and 648: CMS-1403-FC groups must have a part
- Page 649: CMS-1403-FC selected for inclusion
- Page 653 and 654: CMS-1403-FC proposed HIV/AIDS measu
- Page 655 and 656: CMS-1403-FC set of denominator spec
- Page 657 and 658: CMS-1403-FC results, for this purpo
- Page 659 and 660: CMS-1403-FC informed decision-makin
- Page 661 and 662: CMS-1403-FC Comment: Several commen
- Page 663 and 664: CMS-1403-FC prior commitments that
- Page 665 and 666: CMS-1403-FC groups who successfully
- Page 667 and 668: CMS-1403-FC ● Eligible profession
- Page 669 and 670: CMS-1403-FC patients, families, and
- Page 671 and 672: CMS-1403-FC that have satisfactoril
- Page 673 and 674: CMS-1403-FC e-prescribing quality m
- Page 675 and 676: CMS-1403-FC Douglas S. and Friedman
- Page 677 and 678: CMS-1403-FC subsequent year, if the
- Page 679 and 680: CMS-1403-FC eligible professional f
- Page 681 and 682: CMS-1403-FC and is included in the
- Page 683 and 684: CMS-1403-FC The measure becomes app
- Page 685 and 686: CMS-1403-FC is, Measure #125) appli
- Page 687 and 688: CMS-1403-FC outpatient setting. Whi
- Page 689 and 690: CMS-1403-FC ability of an electroni
- Page 691 and 692: CMS-1403-FC October 2005 (hereinaft
- Page 693 and 694: CMS-1403-FC We are aware that there
- Page 695 and 696: CMS-1403-FC provided during the enc
- Page 697 and 698: CMS-1403-FC denominator of a measur
- Page 699 and 700: CMS-1403-FC cases. If the is determ
<strong>CMS</strong>-1403-FC<br />
patients required by applicable reporting criteria<br />
(described above in section II.O1.b.ii.).<br />
TABLE 19: Final Measures Selected for 2009 Diabetes<br />
Mellitus Measures Group<br />
Measure Title Measure Source<br />
1. Diabetes Mellitus: Hemoglobin A1c Poor Control in Diabetes Mellitus NCQA<br />
2. Diabetes Mellitus: Low Density Lipoprotein (LDL-C) Control in Diabetes<br />
Mellitus<br />
NCQA<br />
3. Diabetes Mellitus: High Blood Pressure Control in Diabetes Mellitus NCQA<br />
117. Diabetes Mellitus: Dilated Eye Exam in Diabetic Patient NCQA<br />
119. Diabetes Mellitus: Urine Screening for Microalbumin or Medical Attention<br />
for Nephropathy in Diabetic Patients<br />
NCQA<br />
Diabetes Mellitus: Foot Exam NCQA<br />
TABLE 20: Final Measures Selected for 2009 CKD Measures<br />
Group<br />
Measure Title Measure Source<br />
121. Chronic Kidney Disease (CKD): Laboratory Testing (Calcium,<br />
AMA-PCPI<br />
Phosphorus, Intact Parathyroid Hormone (iPTH) and Lipid Profile)<br />
122. Chronic Kidney Disease (CKD): Blood Pressure Management AMA-PCPI<br />
123. Chronic Kidney Disease (CKD): Plan of Care: Elevated Hemoglobin for<br />
Patients Receiving Erythropoiesis - Stimulating Agents (ESA)<br />
AMA-PCPI<br />
Chronic Kidney Disease (CKD): Referral for Arteriovenous AV) Fistula AMA-PCPI<br />
Chronic Kidney Disease (CKD): Influenza Immunization AMA-PCPI<br />
TABLE 21: Final Measures Selected for 2009 Preventive Care<br />
Measures Group<br />
Measure Title Measure Source<br />
39. Screening or Therapy for Osteoporosis for Women Aged 65 Years and<br />
Older<br />
AMA-PCPI/NCQA<br />
48. Urinary Incontinence: Assessment of Presence or Absence of Urinary<br />
Incontinence in Women Aged 65 Years and Older<br />
AMA-PCPI/NCQA<br />
110. Preventive Care and Screening: Influenza Immunization for Patients ≥ 50<br />
AMA-PCPI<br />
Years Old<br />
111. Preventive Care and Screening: Pneumonia Vaccination for Patients 65<br />
years and Older<br />
NCQA<br />
112. Preventive Care and Screening: Screening Mammography NCQA<br />
113. Preventive Care and Screening: Colorectal Cancer Screening NCQA<br />
114. Preventive Care and Screening: Inquiry Regarding Tobacco Use AMA-PCPI<br />
650